Down-regulation of occludin expression in astrocytes by tumour necrosis factor (TNF) is mediated via TNF type-1 receptor and nuclear factor-kappa B activation
M. Wachtel et al., Down-regulation of occludin expression in astrocytes by tumour necrosis factor (TNF) is mediated via TNF type-1 receptor and nuclear factor-kappa B activation, J NEUROCHEM, 78(1), 2001, pp. 155-162
Tight junctions form the diffusion barrier of brain microcapillary endothel
ial cells and support cell polarity. Also astrocytes express tight junction
components such as occludin, claudin-1, ZO-1 and ZO-2, but do not establis
h a permeability barrier. However, little is known about the function and r
egulation of these molecules in astrocytes. We studied the impact of tumour
necrosis factor (TNF) on occludin and ZO-1 expression in astrocytes. TNF d
ecreased occludin, but not ZO-1 expression, in brain microcapillary endothe
lial cells, as well as in epithelial cells. occludin expression was not inf
luenced by TNF. Removal of TNF from astrocytes restored the basal level of
occludin. Down-regulation was inhibited by caffeic acid phenethyl ester, a
specific inhibitor of nuclear factor-kappaB (NF-kappaB) activation. Exposur
e of astrocytes isolated from mice deficient in either TNF type-1 receptor
(TNFR1), TNF type-2 receptor (TNFR2), or both, respectively, revealed that
downregulation was mediated entirely by TNFR1. ZO-1, which can interact wit
h occludin, was found to cc-precipitate connexin43, but not occludin, These
findings demonstrate that TNF selectively down-regulates occludin in astro
cytes, but not in cells forming established tight junctions, through TNFR1
and suggest that NF-kappaB is involved as a negative regulator.